Key Points: Among the studies included, women were first authors of minority of the publications, and this trend persisted over the 20 years. Crude citation rates were lower in papers with female first authors; the gender of the author was not independently associated with citation metrics.
Background: Historically, women's scientific contributions have been under-recognized.
Key Points: Women are under-represented in high-impact nephrology trials. Trends remain consistent over the past 20 years and on the basis of target condition. Addressing the imbalanced enrollment of women in trials could improve disparities in care and outcomes of kidney disease.
View Article and Find Full Text PDFSignificance Statement: Racial and ethnic disparities in clinical trial enrollment are well described. However, whether these disparities are present in nephrology randomized clinical trials has not been previously reported. We performed a systematic review and meta-analysis of 380 randomized clinical trials involving different aspects of kidney disease published between 2000 and 2021.
View Article and Find Full Text PDF